Dexcom Executive VP, Chief Commercial Officer to Retire

SAN DIEGO—Dexcom, a diabetes management and continuous glucose monitoring system company, announced that its executive VP and chief commercial officer, Teri Lawver, will retire at the end of the year. The retirement announcement was included in the company’s recent third quarter results released on Oct. 24. Lawver joined the company in Jan. 2023, and will continue to serve as the company’s special advisor through early 2025.

Kevin Sayer, chairman, president and CEO of Dexcom, plans to lead the commercial organization and conduct a global search for a new chief commercial officer. 

“I want to personally thank Teri for her strong leadership and dedication, as seen most clearly through the successful launches of ‘G7’ and ‘Stelo,’” Sayer said. “I look forward to guiding us through this transition phase as we capitalize on the incredible opportunity ahead.”

Teri holds a Master of Business Administration from Duke University’s Fuqua School of Business, as well as a Bachelor of Science degree from Georgetown University.